These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21277534)

  • 21. Oncogene-induced senescence and melanoma: where do we stand?
    Peeper DS
    Pigment Cell Melanoma Res; 2011 Dec; 24(6):1107-11. PubMed ID: 22018309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
    Pho L; Grossman D; Leachman SA
    Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of DNA repair pathways is associated with metastasis in melanoma patients.
    Kauffmann A; Rosselli F; Lazar V; Winnepenninckx V; Mansuet-Lupo A; Dessen P; van den Oord JJ; Spatz A; Sarasin A
    Oncogene; 2008 Jan; 27(5):565-73. PubMed ID: 17891185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
    Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ
    Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification of the hereditary variants of skin melanoma].
    Kazubskaia TP; Kozlova VM; Musatov VK; Mikhaĭlovskiĭ AV; Shabanov MA; Trofimov EI; Sel'chuk VIu; Gar'kavtseva RF
    Genetika; 2004 Jan; 40(1):88-96. PubMed ID: 15027204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
    J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular patterns in melanoma and therapeutic targets.
    Chua RA; Arbiser JL
    G Ital Dermatol Venereol; 2010 Oct; 145(5):597-602. PubMed ID: 20930694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
    Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
    Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanoma genetics: the other side.
    Bis S; Tsao H
    Clin Dermatol; 2013; 31(2):148-55. PubMed ID: 23438378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma risk factors and atypical moles.
    Williams ML; Sagebiel RW
    West J Med; 1994 Apr; 160(4):343-50. PubMed ID: 8023484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Melanoma of the skin: clinico-genetic studies].
    Sitnikova TS; Gar'kavtseva RF; Nefedov MD; Demidov LV
    Vopr Onkol; 1990; 36(8):922-7. PubMed ID: 2219832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kinase inhibitors for the therapy of malignant melanoma].
    Becker JC; Schrama D; Bröcker EB; Houben R
    J Dtsch Dermatol Ges; 2005 Oct; 3(10):762-7. PubMed ID: 16194153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple interpretations of cancer risks from body mole counts in preventive care.
    Fusaro RM
    Arch Dermatol; 2001 Jun; 137(6):823. PubMed ID: 11405784
    [No Abstract]   [Full Text] [Related]  

  • 34. Dysplastic nevus syndrome--biological significance.
    Elder DE
    Semin Oncol; 1988 Dec; 15(6):529-40. PubMed ID: 3206238
    [No Abstract]   [Full Text] [Related]  

  • 35. [Etiopathogenesis of malignant melanoma of the skin. II. Disease factors inherent in the organism].
    Nigro MA; Castellani L; Chieregato C
    G Ital Dermatol Venereol; 1990 Mar; 125(3):111-6. PubMed ID: 2198228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Segregation analysis of total nevus density and estimation of lifetime risk and average onset age of melanoma.
    Farrer LA; Myers RH; Cupples LA
    Cytogenet Cell Genet; 1992; 59(2-3):197-9. PubMed ID: 1737499
    [No Abstract]   [Full Text] [Related]  

  • 37. Future advances in melanoma research.
    Hornyak TJ
    Clin Plast Surg; 2010 Jan; 37(1):169-76. PubMed ID: 19914467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.
    Claps G; Cheli Y; Zhang T; Scortegagna M; Lau E; Kim H; Qi J; Li JL; James B; Dzung A; Levesque MP; Dummer R; Hayward NK; Bosenberg M; Brown KM; Ronai ZA
    Cell Rep; 2016 May; 15(9):1884-92. PubMed ID: 27210757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma.
    Miller AJ; Mihm MC
    N Engl J Med; 2006 Jul; 355(1):51-65. PubMed ID: 16822996
    [No Abstract]   [Full Text] [Related]  

  • 40. Multivariate genetic analysis of nevus measurements and melanoma.
    Blangero J; Williams-Blangero S; Kammerer CM; Towne B; Konigsberg LW
    Cytogenet Cell Genet; 1992; 59(2-3):179-81. PubMed ID: 1737493
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.